Kellie Jones Weddle

Photo of Kellie Jones Weddle
Clinical Professor of Pharmacy Practice


1998 PharmD, University of Kentucky
1997 BS, Pharmacy, University of Kentucky
1993 Associate of Arts, St. Catharine College


Retrospective Review of Adult Patients with Solid Tumor Cancers Receiving Rivaroxaban Therapy:Assessment of Associated Bleeding Risks. 2016

Retrospective review of ifosfamide associated encephalopathy for patients admitted to the inpatientoncology unit at the Indianapolis University (IU) Health, University Hospital, Simon Cancer Center. 2016

Compliance with 2010 Infectious Diseases Society of America (IDSA) neutropenic fever guidelines amongpatients with fever and neutropenia. 2012

Retrospective review of pharmacologic and non-pharmacologic risk factors influencing risk of patient falls in an inpatient oncology setting. 2011 

An Oncology Focused Clinical and Research Experience in Eldoret, Kenya.  SAIL Grant Award Winner. Purdue University 2011.

Retrospective review of success rates and toxicities of intraperitoneal chemotherapy for ovarian cancer compared to the published standard of care for intraperitoneal chemotherapy. 2010

Evaluation of the addition of premedications to carboplatin to prevent hypersensitivity reactions in ovarian cancer patients. 2007-2009   

Evaluation of residual toxicity and time to recurrence following intraperitoneal chemotherapy for the treatment of ovarian cancer. 2008
Patient satisfaction with chemotherapy education in academic vs. community setting. 2006-2007

Retrospective chart review of breast cancer patients followed by an anticoagulation management service (AMS): quality assessment. 2005–2006  


PHRM 404, Integrated Lab

PHRM 490, Pharmaceutical Care in Oncology

PHRM 860, Professional Program Laboratory V

PHRM 864, Integrated Pharmacotherapy IV

PHRM 880, Purdue APPE RotationCLPH 490, Dossier Analysis and Formulary Management

CLPH 873, Pathophysiology and Therapeutics III

Honors and Credentials

Fellow, Hematology Oncology Pharmacy Association

Fellow, American College of Clinical Pharmacy

Purdue College of Pharmacy Faculty Preceptor of the Year

The Apple Award, “A Salute to Health Care Education,” nominated by patients

Clinical Practice

Clinical Pharmacy Specialist-Hematology/Oncology, Eskenazi Health, Indianapolis, IN

Representative Publications

1. Mach CM, Lapp EA, Weddle KJ, Hunter RJ, Burns KA, Parker C, Brown J, Smith JA. Adjunct histamine blockers as premedications to prevent carboplatin hypersensitivity reactions. Pharmacotherapy. 2016 Mar 15 doi:10.1002/phar.1739. [Epub ahead of print].
2. Jones KL. Breast cancer. In B Alldredge, R Corelli, M Ernst, B. Joseph Guglielmo, P Jacobson, W Kradjan, B Williams, eds. Applied Therapeutics. The Clinical Use of Drugs. 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2013:2197-2209.
3. Kiel P, Fausel CA, Jones KL.  Testicular germ cell tumors, a history of “if you don’t cure the first time, try, try, again.” J Hematol Oncol Pharm. 2012; 2:85-98.
4. Jones KL, Barnett C, Gauthier M, Boster B, Espirito JL, Michaud LB.  Clinical outcomes of a pharmacist managed anticoagulation service for breast cancer patients. J Oncol Pharm Pract. 2012; 18(1):122-127.
5. Jones KL. Cancer screening and prevention. In: Richardson M, Chant C, Chessman KH, Finks SW, Hemstreet BA, Hume AL, et al, eds. Pharmacotherapy Self-Assessment Program, 7th ed. Oncology. Lenexa, KS: American College of Clinical Pharmacy, 2011:7-23.
6. Pitello N, Treon M, Jones KL, Kiel PJ.  Approaches for administering chemotherapy in the intensive care unit. Curr Drug Saf. 2010; 5(1):22-32.
7. Jones KL, Buzdar AU. Evolving novel anti-HER2 strategies. Lancet Oncol. 2009; 10:1179-87.
8. Jones KL, Buzdar A.  A review of adjuvant hormonal therapy in breast cancer.  Endocr Relat Cancer. 2004; 11:391-406.
9. Michaud LB, Karpinski JP, Jones KL, Espirito J. Dietary supplements in patients with cancer: risks and key concepts, part 1: Am J Health Syst Pharm 2007; 64:369-81.
10. Navo MA, Phan J, Vaughan C, Palmer JL, Michaud L, Jones KL, Bodurka DC, Basen-Engquist K, Hortobagyi GN, Kavanagh JJ, Smith JA.  An assessment of the utilization of complementary and alternative medications in women with gynecologic or breast malignancies. J Clin Oncol. 2004; Feb 15:671-7.

Mega Menu Visual Content